Abstract
Introduction
Benzamides correspond to a carbonic acid amide of the benzoic acid. Amide has the general formula RCO-NH2, in such compounds the carbon atom being attached to oxygen and also a hydroxyl group.
Generally, amides are divided into distinct subclasses according to the number of nitrogen substituents.
Primary amide results through NH2 replacement of the carboxylic hydroxyl group, and usually it has a higher boiling point than secondary and tertiary amides. The secondary and tertiary amides result when one or both hydrogens are replaced by other groups in primary amides (1) (2) (3) .
From the group of benzamides, two active substances have been extensively in use in psychiatry and other related medical fields, namely Sulpiride and Amisulpiride. Remoxipride is another benzamide that was removed from the market due to life threatening side effects in 1993 (4) (5) (6) . Depending on the compound, benzamides have antidepressant activity, anticonvulsant activity, anti-inflammatory activity, analgesic properties, serotonin (5-HT) activity, antitumor activity, and antimicrobial activity (7) (8) .
The purpose of this study was to identify new molecules with a higher degree of selectivity on receptors implicated in neurotransmission that is directly involved in the normal psychological functions, but with a lower rate of side effects.
Materials and Methods
A sample of 80 white NMRI mice having reached maturity, weighing 23±2g, divided in 4 groups, was used in this study. They were treated for 21 days as follows. 
Results
The evasion-investigation test yielded the following results: In our study, compound II5C induced a statistically significant increase in motor activity (distance and speed) after 4 days of treatment (+71.34% and +73.14%) and after 22 days of treatment (+17.76% and +17.52%).
Compound I5C induced a statistically significant decrease in motor activity (distance and speed) after 4 days of treatment (-11.45% and -12.78%) and after 22 days of treatment (-11.82% and -12.31%). 
Conclusions
The lack of effective treatment for many psychiatric diseases and the side effect complexity of many current drugs used for this purpose justify the need for medical research to find new alternatives (9).
After performing two specific tests relevant for the normal functioning of the central nervous system, our findings revealed the following:
Compounds I5C and II5C decreased in a statistically significant manner the evasioninvestigation capacity of mice (-45.16% and -45.62%),
suggesting an intense central effect.
Compound I5C induced a statistically significant decrease in motor activity, suggesting a sedative type of antipsychotic profile.
Compound II5C induced a statistically significant increase in motor activity, suggesting a possible incisive type of neuroleptic profile.
Further studies are necessary in order to confirm these preliminary findings.
